One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Recommended Papers of 2022 From the TMR Editorial Board
Sunny Dzik a,†,∗, Michael Murphy
doi : 10.1016/j.tmrv.2022.12.001
Volume 37, Issue 1, January 2023, Pages 1-6
Monkeypox and Transfusion Safety
Roger Y. Dodd a,∗, Susan L. Stramer
doi : 10.1016/j.tmrv.2022.09.004
Volume 37, Issue 1, January 2023, Pages 7-9
In May of 2022, a multinational outbreak of monkeypox was recognized. It expanded rapidly and over the following three-plus months, more than 50,000 cases were reported from 100 countries, largely among gay or bisexual men.
Plasma Exchange in Alzheimer's Disease
Lucas Rohrer a,1,∗, Muharrem Yunce b,1, Thomas J. Montine b, Hua Shan
doi : 10.1016/j.tmrv.2022.09.005
Volume 37, Issue 1, January 2023, Pages 10-15
Therapeutic plasma exchange (TPE) has traditionally been used to selectively remove pathologic contents including autoantibodies, abnormal proteins, immune complexes, or toxins from a patient's plasma.
State of the Evidence: Drug Removal via Apheresis
Thomas C Binns∗, Nataliya Sostin, Christopher A Tormey
doi : 10.1016/j.tmrv.2022.12.003
Volume 37, Issue 1, January 2023, Pages 16-20
Therapeutic apheresis refers to a diversity of procedures in which specific hematologic components (e.g., plasma, erythrocytes, leukocytes, etc.) with pathological associations are removed from circulation (with possible replacement) in order to treat a variety of disease processes.
Alloantigen Copy Number as a Critical Factor in RBC Alloimmunization
Seema R. Patel a, Cheryl L. Maier b, James C. Zimring
doi : 10.1016/j.tmrv.2022.12.009
Volume 37, Issue 1, January 2023, Pages 21-26
RBC alloimmunization remains a significant barrier to ongoing transfusion therapy leading to morbidity, and in extreme cases mortality, due to delayed or insufficient units of compatible RBCs.
Eligibility Considerations for Female Whole Blood Donors: Hemoglobin Levels and Iron Status in a Nationally Representative Population
Bryan R. Spencer a,∗, Jodie L. White b, Eshan U. Patel b,c, Ruchika Goel b, Evan M. Bloch b, Aaron AR Tobian
doi : 10.1016/j.tmrv.2022.11.001
Volume 37, Issue 1, January 2023, Pages 27-35
Blood collection from minority populations improves the transfusion support of patients with sickle cell disease and thalassemia, but efforts are challenged by high deferral rates for hemoglobin (Hb) eligibility thresholds.
Academic Productivity of Early Career Transfusion Medicine Specialists: A Workforce Study
Yvette C. Tanhehco a,∗, Tina S. Ipe b,c, Garrett S. Booth d, Brian D. Adkins
doi : 10.1016/j.tmrv.2022.09.006
Volume 37, Issue 1, January 2023, Pages 36-40
Blood Banking/Transfusion Medicine (BB/TM) specialists oversee all aspects of blood component transfusions and are often involved with apheresis, coagulation, and cellular therapy services as well.
RESPONSE OF LYMPHOPENIC PLATELETPHERESIS DONORS TO COVID-19 VACCINATION
doi : 10.1016/j.tmrv.2022.12.004
Volume 37, Issue 1, January 2023, Page 41
Fibrinogen Concentrate vs Cryoprecipitate for Treating Acquired Hypofibrinogenemia in Bleeding Adult Cardiac Surgical Patients: A Within-trial Economic Evaluation of the FIBRES Randomized Controlled Trial
doi : 10.1016/j.tmrv.2022.12.005
Volume 37, Issue 1, January 2023, Pages 41-42
SARS-CoV-2 Seroprevalence in the Vaccine Era: The Canadian Blood Services Serosurvey January to November 2021
doi : 10.1016/j.tmrv.2022.12.006
Volume 37, Issue 1, January 2023, Page 42
Assessment of Hemoglobin-Oxygen Affinity of RBCs of Different Senescence Levels During Hypothermic Storage in Old Senior and Teenage Donors
doi : 10.1016/j.tmrv.2022.12.007
Volume 37, Issue 1, January 2023, Pages 42-43
ASFA's Response to 'Gender Inequities in Transfusion Medicine Society Recognition Awards'
doi : 10.1016/j.tmrv.2022.07.002
Volume 37, Issue 1, January 2023, Page 44
